Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Blood|February 15, 2008
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimatedSanne Lugthart, Ellen van Drunen, Yvette van Norden, et al.Blood|June 30, 2016
Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemiaEduard J Libourel, Clara P W Klerk, Yvette van Norden, et al.Cancer Immunology, Immunotherapy : CII|June 29, 2007
No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodiesJanet W de Beukelaar, Georges M Verjans, Yvette van Norden, et al.Journal of Neuroimmunology|March 25, 2008
B and T cell imbalances in CSF of patients with Hu-antibody associated PNSMarieke de Graaf, Janet de Beukelaar, Jelmer Bergsma, et al.British Journal of Haematology|August 27, 2010
Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysisMascha Schuurmans, Jacoline E C Bromberg, Jeanette Doorduijn, et al.BMC Cancer|June 13, 2023
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trialJoris B W Elbers, Pascal A Gunsch, Reno Debets, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2023
Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse gliomaJaap P M Jaspers, Walter Taal, Yvette van Norden, et al.Blood Advances|September 16, 2020
Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantationBurak Kalin, Yvette van Norden, Michel van Gelder, et al.Blood|March 27, 2014
Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profilingErdogan Taskesen, Marije Havermans, Kirsten van Lom, et al.JAMA Oncology|August 29, 2024
Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers: A Systematic ReviewSjoerd J F Hermans, Niek G van der Maas, Yvette van Norden, et al.Pageof 4